220 related articles for article (PubMed ID: 20958930)
1. A comparative antibody study of the potential susceptibility of Thoroughbred and non-Thoroughbred horse populations in Ireland to equine influenza virus.
Gildea S; Arkins S; Cullinane A
Influenza Other Respir Viruses; 2010 Nov; 4(6):363-72. PubMed ID: 20958930
[TBL] [Abstract][Full Text] [Related]
2. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
[TBL] [Abstract][Full Text] [Related]
3. Equine Influenza Virus and Vaccines.
Oladunni FS; Oseni SO; Martinez-Sobrido L; Chambers TM
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452521
[TBL] [Abstract][Full Text] [Related]
4. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
[TBL] [Abstract][Full Text] [Related]
5. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
6. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
Gildea S; Sanchez Higgins MJ; Johnson G; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2016 Sep; 10(5):433-7. PubMed ID: 27169603
[TBL] [Abstract][Full Text] [Related]
7. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
[TBL] [Abstract][Full Text] [Related]
8. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
Gildea S; Quinlivan M; Murphy BA; Cullinane A
Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
[TBL] [Abstract][Full Text] [Related]
9. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
Gildea S; Arkins S; Walsh C; Cullinane A
Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
[TBL] [Abstract][Full Text] [Related]
11. Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza.
El-Hage CM; Savage CJ; Minke JM; Ficorilli NP; Watson J; Gilkerson JR
Equine Vet J; 2013 Mar; 45(2):235-9. PubMed ID: 22943193
[TBL] [Abstract][Full Text] [Related]
12. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
Paillot R; Prowse L
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
[TBL] [Abstract][Full Text] [Related]
15. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.
Ryan M; Gildea S; Walsh C; Cullinane A
Equine Vet J; 2015 Nov; 47(6):662-6. PubMed ID: 25238593
[TBL] [Abstract][Full Text] [Related]
16. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
[TBL] [Abstract][Full Text] [Related]
17. A Brief Introduction to Equine Influenza and Equine Influenza Viruses.
Chambers TM
Methods Mol Biol; 2020; 2123():355-360. PubMed ID: 32170701
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological survey of equine influenza in horses in India.
Mavadiya SV; Raval SK; Mehta SA; Kanani AN; Vagh AA; Tank PH; Patel PR
Rev Sci Tech; 2012 Dec; 31(3):871-5. PubMed ID: 23520740
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak.
Bryant NA; Paillot R; Rash AS; Medcalf E; Montesso F; Ross J; Watson J; Jeggo M; Lewis NS; Newton JR; Elton DM
Vet Res; 2010; 41(2):19. PubMed ID: 19863903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
